The researchers found that the estimated mean change in hemoglobin A1c (HbA1c) after 40 weeks was 1.8, 1.5, and 0.1 percentage points for cagrilintide-semaglutide 2.4 mg each, 1.0 mg each, and placebo, respectively
People sensitive to caffeine or with blood sugar issues may want to limit intake
By design, they support an employee-led benefits framework that puts choice and autonomy in the hands of each person, aligning personal needs with organizational culture
Other notable risks include diabetic retinopathy complicationsseen previously with lowerdose injectable semaglutide in highrisk type 2 diabetes cohortsand modest increases in resting heart rate
Semaglutide 1 mg lowered HbA1c by 0.24 percentage points more than dulaglutide 3 mg and had similar results to dulaglutide 4.5 mg
In general, the majority of studies suggest that the risk of side effects with DPP-4 inhibitors is equivalent to that of a placebo (inactive pill) [14]